These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25284324)

  • 61. Thalamic hyperdensity--is it a diagnostic marker for Sandhoff disease?
    Calişkan M; Ozmen M; Beck M; Apak S
    Brain Dev; 1993; 15(5):387-8. PubMed ID: 8279657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.
    Kılıç M; Kasapkara ÇS; Kılavuz S; Mungan NÖ; Biberoğlu G
    Metab Brain Dis; 2019 Apr; 34(2):495-503. PubMed ID: 30712135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
    Utsumi K; Tsuji A; Kase R; Tanaka A; Tanaka T; Uyama E; Ozawa T; Sakuraba H; Komaba Y; Kawabe M; Iino Y; Katayama Y
    Acta Neurol Scand; 2002 Jun; 105(6):427-30. PubMed ID: 12027830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical consequences of mutations causing the GM2 gangliosidoses.
    Mahuran DJ
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
    Arthur JR; Lee JP; Snyder EY; Seyfried TN
    Neurochem Res; 2012 Jun; 37(6):1335-43. PubMed ID: 22367451
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease).
    Muldoon LL; Neuwelt EA; Pagel MA; Weiss DL
    Am J Pathol; 1994 May; 144(5):1109-18. PubMed ID: 8178934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GM2 gangliosidosis variant B1 neuroradiological findings.
    Grosso S; Farnetani MA; Berardi R; Margollicci M; Galluzzi P; Vivarelli R; Morgese G; Ballestri P
    J Neurol; 2003 Jan; 250(1):17-21. PubMed ID: 12527987
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.
    Hall P; Minnich S; Teigen C; Raymond K
    Curr Protoc Hum Genet; 2014 Oct; 83():17.16.1-8. PubMed ID: 25271840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Genetic deficiencies of beta-N-acetylhexosaminidase A and B: Tay-Sachs and Sandhoff diseases (GM2-gangliosidosis)].
    Suzuki K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):721-7. PubMed ID: 2978703
    [No Abstract]   [Full Text] [Related]  

  • 71. Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
    Kitakaze K; Tasaki C; Tajima Y; Hirokawa T; Tsuji D; Sakuraba H; Itoh K
    Biochem Biophys Rep; 2016 Sep; 7():157-163. PubMed ID: 28955902
    [TBL] [Abstract][Full Text] [Related]  

  • 72. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
    Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.
    Arfi A; Zisling R; Richard E; Batista L; Poenaru L; Futerman AH; Caillaud C
    J Neurochem; 2006 Mar; 96(6):1572-9. PubMed ID: 16441513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.
    Kitakaze K; Mizutani Y; Sugiyama E; Tasaki C; Tsuji D; Maita N; Hirokawa T; Asanuma D; Kamiya M; Sato K; Setou M; Urano Y; Togawa T; Otaka A; Sakuraba H; Itoh K
    J Clin Invest; 2016 May; 126(5):1691-703. PubMed ID: 27018595
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
    Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
    Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained normalization of neurological disease after intracranial gene therapy in a feline model.
    McCurdy VJ; Johnson AK; Gray-Edwards HL; Randle AN; Brunson BL; Morrison NE; Salibi N; Johnson JA; Hwang M; Beyers RJ; Leroy SG; Maitland S; Denney TS; Cox NR; Baker HJ; Sena-Esteves M; Martin DR
    Sci Transl Med; 2014 Apr; 6(231):231ra48. PubMed ID: 24718858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant.
    Martin DR; Krum BK; Varadarajan GS; Hathcock TL; Smith BF; Baker HJ
    Exp Neurol; 2004 May; 187(1):30-7. PubMed ID: 15081585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurochemical, morphological, and neurophysiological abnormalities in retinas of Sandhoff and GM1 gangliosidosis mice.
    Denny CA; Alroy J; Pawlyk BS; Sandberg MA; d'Azzo A; Seyfried TN
    J Neurochem; 2007 Jun; 101(5):1294-302. PubMed ID: 17442056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.
    Jeyakumar M; Butters TD; Cortina-Borja M; Hunnam V; Proia RL; Perry VH; Dwek RA; Platt FM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6388-93. PubMed ID: 10339597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.